APRE
Price
$1.62
Change
+$0.12 (+8.00%)
Updated
Apr 24, 04:55 PM (EDT)
Capitalization
8.4M
KPRX
Price
$3.20
Change
+$0.08 (+2.56%)
Updated
Apr 24, 04:57 PM (EDT)
Capitalization
9.06M
Ad is loading...

APRE vs KPRX

Header iconAPRE vs KPRX Comparison
Open Charts APRE vs KPRXBanner chart's image
Aprea Therapeutics
Price$1.62
Change+$0.12 (+8.00%)
Volume$400
Capitalization8.4M
Kiora Pharmaceuticals
Price$3.20
Change+$0.08 (+2.56%)
Volume$100
Capitalization9.06M
APRE vs KPRX Comparison Chart
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. KPRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Hold and KPRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (APRE: $1.52 vs. KPRX: $3.12)
Brand notoriety: APRE and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 28% vs. KPRX: 59%
Market capitalization -- APRE: $8.4M vs. KPRX: $9.06M
APRE [@Biotechnology] is valued at $8.4M. KPRX’s [@Biotechnology] market capitalization is $9.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileKPRX’s FA Score has 3 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • KPRX’s FA Score: 3 green, 2 red.
According to our system of comparison, KPRX is a better buy in the long-term than APRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 4 TA indicator(s) are bullish while KPRX’s TA Score has 5 bullish TA indicator(s).

  • APRE’s TA Score: 4 bullish, 3 bearish.
  • KPRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both APRE and KPRX are a good buy in the short-term.

Price Growth

APRE (@Biotechnology) experienced а -1.11% price change this week, while KPRX (@Biotechnology) price change was +13.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

APRE is expected to report earnings on Mar 25, 2025.

KPRX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KPRX($9.06M) has a higher market cap than APRE($8.4M). KPRX YTD gains are higher at: -5.455 vs. APRE (-53.799). KPRX has higher annual earnings (EBITDA): 2.39M vs. APRE (-14.75M). KPRX has more cash in the bank: 29M vs. APRE (26.2M). APRE has less debt than KPRX: APRE (0) vs KPRX (72.6K). KPRX has higher revenues than APRE: KPRX (16M) vs APRE (0).
APREKPRXAPRE / KPRX
Capitalization8.4M9.06M93%
EBITDA-14.75M2.39M-616%
Gain YTD-53.799-5.455986%
P/E RatioN/A3.59-
Revenue016M-
Total Cash26.2M29M90%
Total Debt072.6K-
FUNDAMENTALS RATINGS
KPRX: Fundamental Ratings
KPRX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APREKPRX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSIDX16.27N/A
N/A
Fidelity Advisor Strategic Div & Inc I
NSEPX19.01N/A
N/A
Columbia Select Large Cap Equity Inst
BRWIX35.91N/A
N/A
AMG Boston Common Global Impact I
TLARX9.97N/A
N/A
Transamerica Large Core ESG R
PAHVX6.27N/A
N/A
PGIM Jennison NextGeneration Glb Opps R6

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-1.62%
ATOS - APRE
32%
Poorly correlated
+11.25%
KPRX - APRE
31%
Poorly correlated
+3.31%
NKTR - APRE
29%
Poorly correlated
+3.28%
CRVS - APRE
28%
Poorly correlated
+5.71%
ABOS - APRE
28%
Poorly correlated
+3.86%
More

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been loosely correlated with OVID. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KPRX jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
+3.31%
OVID - KPRX
36%
Loosely correlated
+12.07%
AVTE - KPRX
34%
Loosely correlated
-0.72%
SYRE - KPRX
33%
Poorly correlated
+1.86%
VANI - KPRX
33%
Poorly correlated
+1.86%
APRE - KPRX
31%
Poorly correlated
-1.62%
More